Onco Wiki / Krankheit

Basalzellkarzinom (BCC)

Deterministische Ansicht der Quelle YAML Entität. Klinische Autorität bleibt mit den zitierten Quell-IDs und Rezensenten Sign-off Zustand.

IDDIS-BCC
ArtErkrankung
Aliase
BCCBasalzellkarzinomBasalzell-HautkrebsBasaliomNagetiergeschwürБазально-клітинна карцинома (БКК)
Statusreviewed 2026-05-04 | pending_clinical_signoff
ErkrankungenNone declared
QuellenSRC-NCCN-MELANOMA-2025 SRC-NCCN-SKIN-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Quelle: YAML

icd_o_3_morphology8090/3
icd_o_3_topography["C44"]
icd_10C44
who_classificationWHO-Klassifikation von Hauttumoren 5. ed (2023): Basalzellkarzinom

Fähigkeiten

Anmerkungen

The vast majority of BCCs are cured with surgery or radiation. Hedgehog inhibitors (vismodegib, sonidegib) are approved only for locally advanced unresectable or metastatic BCC — a small fraction of all BCCs. Gorlin syndrome (PTCH1 germline) warrants genetic counseling and lifelong surveillance. SMO inhibitors cause significant side effects (muscle cramps, alopecia, dysgeusia, weight loss) limiting long-term use. Cemiplimab (anti-PD-1) is FDA-approved for locally advanced/metastatic BCC after HHI failure.

Verwendet von

Therapeutische Relevanz

Algorithmen

Anwendungsgebiet

Fragebogen

Warnhinweis